دورية أكاديمية
Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
| العنوان: | Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study |
|---|---|
| المؤلفون: | Adams, S., Loi, S., Toppmeyer, D., Cescon, D.W., De Laurentiis, M., Nanda, R., Winer, E.P., Mukai, H., Tamura, K., Armstrong, A., Liu, M.C., Iwata, H., Ryvo, L., Wimberger, P., Rugo, H.S., Tan, A.R., Jia, L., Ding, Y., Karantza, V., Schmid, P. |
| المساهمون: | Merck Sharp & Dohme Corp, Merck & Co. Inc., Kenilworth |
| المصدر: | Annals of Oncology ; volume 30, issue 3, page 405-411 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2019 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1093/annonc/mdy518 |
| الإتاحة: | https://doi.org/10.1093/annonc/mdy518Test https://api.elsevier.com/content/article/PII:S0923753419310762?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753419310762?httpAccept=text/plainTest http://academic.oup.com/annonc/article-pdf/30/3/405/28255067/mdy518.pdfTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.C584B113 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1093/annonc/mdy518 |
|---|